Kevin Sharer at Amgen: Sustaining the High-Growth Company (B) Harvard Case Solution & Analysis

Kevin Sharer, CEO of Amgen, assesses the problems he faced, as the main product has been exposed to the regulatory authorities. "Hide
by William W. George Source: Harvard Business School 5 pages. Publication Date: September 10, 2008. Prod. #: 409037-PDF-ENG

Share This

SALE SALE

Save Up To

30%

IN ONLINE CASE STUDY

FOR FREE CASES AND PROJECTS INCLUDING EXCITING DEALS PLEASE REGISTER YOURSELF !!

Register now and save up to 30%.